OBJECTIVE: To determine whether programmed cell death 4 (PDCD-4) is altered in autologous leiomyoma and myometrial tissues and what microRNA-21's (miR-21) role is in PDCD-4 expression, apoptosis, and translation. DESIGN: Laboratory research. SETTING: Academic medical center. PATIENT(S): Myometrial and leiomyoma tissues from patients with symptomatic leiomyomata. INTERVENTION(S): Tissue analysis and miR-21 knockdown in cultured immortalized myometrial (UtM) and leiomyoma (UtLM) cells. MAIN OUTCOME MEASURE(S): MiR-21 and PDCD-4 mRNA and protein expression. RESULT(S): Leiomyoma tissues robustly expressed the full-length 51 kd isoform of PDCD-4, but normal myometrial tissue had negligible expression. Consistent with autologous tissues, UtLM cells expressed elevated miR-21 and a similar pattern of PDCD-4 compared with UtM cells. Knockdown of miR-21 increased PDCD-4 levels in UtM cells and UtLM cells, indicating that it can regulate PDCD-4 expression. Loss of miR-21 also increased cleavage of caspase-3 (apoptosis marker) and increased phosphorylation of elongation factor-2 (marker of reduced translation) in both cell lines. CONCLUSION(S): Elevated leiomyoma miR-21 levels are predicted to decrease PDCD-4 levels, thus leiomyomas differ from other tumors where loss of PDCD-4 is associated with tumor progression. Our studies indicate regulation of PDCD-4 expression is not a primary miR-21 function in leiomyomas, but instead miR-21 is able to impact cellular apoptosis and translation, through unknown targets, in a manner consistent with its involvement in the pathophysiology of uterine fibroids.
OBJECTIVE: To determine whether programmed cell death 4 (PDCD-4) is altered in autologous leiomyoma and myometrial tissues and what microRNA-21's (miR-21) role is in PDCD-4 expression, apoptosis, and translation. DESIGN: Laboratory research. SETTING: Academic medical center. PATIENT(S): Myometrial and leiomyoma tissues from patients with symptomatic leiomyomata. INTERVENTION(S): Tissue analysis and miR-21 knockdown in cultured immortalized myometrial (UtM) and leiomyoma (UtLM) cells. MAIN OUTCOME MEASURE(S): MiR-21 and PDCD-4 mRNA and protein expression. RESULT(S): Leiomyoma tissues robustly expressed the full-length 51 kd isoform of PDCD-4, but normal myometrial tissue had negligible expression. Consistent with autologous tissues, UtLM cells expressed elevated miR-21 and a similar pattern of PDCD-4 compared with UtM cells. Knockdown of miR-21 increased PDCD-4 levels in UtM cells and UtLM cells, indicating that it can regulate PDCD-4 expression. Loss of miR-21 also increased cleavage of caspase-3 (apoptosis marker) and increased phosphorylation of elongation factor-2 (marker of reduced translation) in both cell lines. CONCLUSION(S): Elevated leiomyomamiR-21 levels are predicted to decrease PDCD-4 levels, thus leiomyomas differ from other tumors where loss of PDCD-4 is associated with tumor progression. Our studies indicate regulation of PDCD-4 expression is not a primary miR-21 function in leiomyomas, but instead miR-21 is able to impact cellular apoptosis and translation, through unknown targets, in a manner consistent with its involvement in the pathophysiology of uterine fibroids.
Authors: Hsin-Sheng Yang; Aaron P Jansen; Anton A Komar; Xiaojing Zheng; William C Merrick; Sylvain Costes; Stephen J Lockett; Nahum Sonenberg; Nancy H Colburn Journal: Mol Cell Biol Date: 2003-01 Impact factor: 4.272
Authors: D D Brandon; C L Bethea; E Y Strawn; M J Novy; K A Burry; M S Harrington; T E Erickson; C Warner; E J Keenan; G M Clinton Journal: Am J Obstet Gynecol Date: 1993-07 Impact factor: 8.661
Authors: Jennifer Condon; Su Yin; Bobbie Mayhew; R Ann Word; W E Wright; J W Shay; William E Rainey Journal: Biol Reprod Date: 2002-08 Impact factor: 4.285
Authors: Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman Journal: Am J Obstet Gynecol Date: 2003-01 Impact factor: 8.661
Authors: James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon Journal: Hum Reprod Update Date: 2014-01-08 Impact factor: 15.610
Authors: Tanvi Arkatkar; Rishein Gupta; Weidang Li; Jieh-Juen Yu; Shradha Wali; M Neal Guentzel; James P Chambers; Lane K Christenson; Bernard P Arulanandam Journal: Immunology Date: 2015-06-29 Impact factor: 7.397
Authors: Aloma L D'Souza; John R Chevillet; Pejman Ghanouni; Xinrui Yan; Muneesh Tewari; Sanjiv S Gambhir Journal: PLoS One Date: 2018-03-16 Impact factor: 3.240